Tuomo Laitinen
- Geriatrics and Gerontology top 5%
- Toxicology top 5%
- Pharmacology top 5%
- Cannabis and Cannabinoid Research 11
- Biotechnology top 5%
- Molecular Biology top 10%
- Receptor Mechanisms and Signaling 7
- Protein Kinase Regulation and GTPase Signaling 7
-
- HIV Research and Treatment 7
-
- HIV/AIDS drug development and treatment 7
-
- Quinazolinone synthesis and applications 7
- Synthesis and biological activity 6
- Click Chemistry and Applications 6
- Co-authors
- Antti PosoChristopher R. M. AsquithJuha RouvinenTapio NevalainenJuha R. SavinainenJarmo T. LaitinenDina Navia‐PaldaniusMikael Peräkylä
- Partner nations
- FinlandUnited StatesGermany
In The Last Decade
Tuomo Laitinen
86 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 105
- Geriatrics and Gerontology 91
- Toxicology 60
- Pharmacology 278
- Biotechnology 130
- Molecular Biology 970
Countries citing papers authored by Tuomo Laitinen
This map shows the geographic impact of Tuomo Laitinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuomo Laitinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuomo Laitinen more than expected).
Fields of papers citing papers by Tuomo Laitinen
This network shows the impact of papers produced by Tuomo Laitinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuomo Laitinen. The network helps show where Tuomo Laitinen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tuomo Laitinen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 0 | |
| 6 | 2020 | 9 | |
| 7 | 2018 | 15 | |
| 8 | 2018 | 1 | |
| 9 | 2017 | 29 | |
| 10 | 2016 | 11 | |
| 11 | 2016 | 32 | |
| 12 | 2015 | 23 | |
| 13 | 2015 | 20 | |
| 14 | 2015 | 10 | |
| 15 | 2014 | 35 | |
| 16 | 2014 | 21 | |
| 17 | 2013 | 85 | |
| 18 | 2007 | 109 | |
| 19 | 2003 | 7 | |
| 20 | 1998 | 13 |
About Tuomo Laitinen
Tuomo Laitinen is a scholar working on Virology, Pharmacology and Molecular Biology, having authored 90 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (11 papers), HIV Research and Treatment (7 papers), Receptor Mechanisms and Signaling (7 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), HIV/AIDS drug development and treatment (7 papers), Quinazolinone synthesis and applications (7 papers), Synthesis and biological activity (6 papers) and Click Chemistry and Applications (6 papers). The work is most often cited by research in Geriatrics and Gerontology (91 citations), Toxicology (60 citations) and Pharmacology (278 citations). Tuomo Laitinen has collaborated with scholars based in Finland, United States and Germany. Frequent co-authors include Antti Poso, Christopher R. M. Asquith, Juha Rouvinen, Tapio Nevalainen, Juha R. Savinainen, Jarmo T. Laitinen, Dina Navia‐Paldanius, Mikael Peräkylä, Teija Parkkari and Michael P. East. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.